Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.1319 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.01 | 0.4894 | 0.4894 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.01 | 0.4894 | 0.4894 |
Giardia lamblia | Kinase, CMGC MAPK | 0.01 | 0.4894 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.704 | 0.704 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.1319 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.01 | 0.4894 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.704 | 0.704 |
Trichomonas vaginalis | CMGC family protein kinase | 0.01 | 0.4894 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0125 | 0.704 | 0.704 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.01 | 0.4894 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0159 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.1319 | 0.5 |
Brugia malayi | RNA binding protein | 0.0125 | 0.704 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.704 | 0.704 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.01 | 0.4894 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0125 | 0.704 | 0.704 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.1319 | 0.1319 |
Loa Loa (eye worm) | RNA binding protein | 0.0125 | 0.704 | 0.704 |
Echinococcus granulosus | tar DNA binding protein | 0.0125 | 0.704 | 0.704 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.01 | 0.4894 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.01 | 0.4894 | 0.4894 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.01 | 0.4894 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.01 | 0.4894 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.1319 | 0.1319 |
Brugia malayi | TAR-binding protein | 0.0125 | 0.704 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.01 | 0.4894 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.704 | 0.704 |
Trichomonas vaginalis | CMGC family protein kinase | 0.01 | 0.4894 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.01 | 0.4894 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.01 | 0.4894 | 0.4894 |
Trypanosoma brucei | protein kinase, putative | 0.01 | 0.4894 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.1319 | 0.1319 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.1319 | 0.1319 |
Trichomonas vaginalis | CMGC family protein kinase | 0.01 | 0.4894 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.1319 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0125 | 0.704 | 0.704 |
Brugia malayi | MAP kinase sur-1 | 0.01 | 0.4894 | 0.6952 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0125 | 0.704 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0159 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.01 | 0.4894 | 0.4894 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0159 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.704 | 0.704 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.01 | 0.4894 | 0.4894 |
Trichomonas vaginalis | CMGC family protein kinase | 0.01 | 0.4894 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = -71.6 % | compound was tested for antipsychotic activity by conditioned avoidance response(CAR) assay in rats with a pretreatment period of 30 min upon intra peritorial administration at a concentration of 5 mg/kg. | ChEMBL. | 9622541 |
Ki (binding) | = 1.1 nM | Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex | ChEMBL. | 9622541 |
Ki (binding) | = 1.1 nM | Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex | ChEMBL. | 9622541 |
Ki (binding) | = 2.3 nM | Binding affinity against Alpha-1 adrenergic receptor from rat cerebral cortex | ChEMBL. | 9622541 |
Ki (binding) | = 2.3 nM | Binding affinity against Alpha-1 adrenergic receptor from rat cerebral cortex | ChEMBL. | 9622541 |
Ki (binding) | = 20 nM | Binding affinity against Dopamine receptor D2 from rat striatum | ChEMBL. | 9622541 |
Ki (binding) | = 20 nM | Binding affinity against Dopamine receptor D2 from rat striatum | ChEMBL. | 9622541 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.